Position in ABBV
as of Jun 30, 2026
· filed Jul 8, 2026
Position Value
$126,549,001
+$21,862,365 QoQ
Shares Held
502,897
+4.5% QoQ
Ownership
0.028%
of shares outstanding
% of Portfolio
0.72%
of 13F equity value
Holder Rank
#219
of 4,153 holders
Holding Since
Sep 2022
16 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Czech National Bank holds $842,887,797 across 9 Drug Manufacturers - General names. ABBV ranks #3 (15.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
225,167 | $270,072,077 | |
| 2 | JNJ |
Johnson & Johnson
|
685,186 | $174,016,688 | |
| 3 | ABBV |
AbbVie Inc.
This page
|
502,897 | $126,549,001 | |
| 4 | MRK |
Merck & Co., Inc.
|
703,007 | $90,336,399 | |
| 5 | AMGN |
Amgen Inc
|
153,622 | $55,629,598 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
353,398 | $44,648,303 | |
| 7 | PFE |
Pfizer Inc
|
1,622,280 | $39,064,502 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
581,252 | $33,491,740 |
All Filings in ABBV
Export CSV
16 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $126,549,001 | 502,897 | Shares | Sole | 2026-07-08 | |
| 2026-03-31 | $104,686,636 | 481,340 | Shares | Sole | 2026-04-13 | |
| 2025-12-31 | $106,483,651 | 466,032 | Shares | Sole | 2026-01-12 | |
| 2025-09-30 | $103,882,504 | 448,659 | Shares | Sole | 2025-10-08 | |
| 2025-06-30 | $80,145,333 | 431,771 | Shares | Sole | 2025-07-09 | |
| 2025-03-31 | $84,955,122 | 405,475 | Shares | Sole | 2025-04-09 | |
| 2024-12-31 | $68,085,932 | 383,151 | Shares | Sole | 2025-01-13 | |
| 2024-09-30 | $71,057,846 | 359,823 | Shares | Sole | 2024-10-07 | |
| 2024-06-30 | $57,716,994 | 336,503 | Shares | Sole | 2024-07-15 | |
| 2024-03-31 | $56,569,000 | 310,648 | Shares | Sole | 2024-04-10 | |
| 2023-12-31 | $47,928,346 | 309,275 | Shares | Sole | 2024-01-08 | |
| 2023-09-30 | $45,984,264 | 308,495 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $28,139,168 | 208,856 | Shares | Sole | 2023-07-11 | |
| 2023-03-31 | $33,202,508 | 208,336 | Shares | Sole | 2023-04-17 | |
| 2022-12-31 | $33,469,107 | 207,098 | Shares | Sole | 2023-01-18 | |
| 2022-09-30 | $27,564,586 | 205,384 | Shares | Sole | 2022-10-31 | |
| No filing history on record for this holder in this stock. | ||||||